EP1963538A2 - Biocapteurs fluorescents différentiels à levure pour la détection et la biodégradation d'agents chimiques - Google Patents
Biocapteurs fluorescents différentiels à levure pour la détection et la biodégradation d'agents chimiquesInfo
- Publication number
- EP1963538A2 EP1963538A2 EP06851299A EP06851299A EP1963538A2 EP 1963538 A2 EP1963538 A2 EP 1963538A2 EP 06851299 A EP06851299 A EP 06851299A EP 06851299 A EP06851299 A EP 06851299A EP 1963538 A2 EP1963538 A2 EP 1963538A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- yeast
- organophosphate
- gene
- paraoxon
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 296
- 239000013043 chemical agent Substances 0.000 title abstract description 35
- 238000001514 detection method Methods 0.000 title description 14
- 238000006065 biodegradation reaction Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 54
- 108090000623 proteins and genes Proteins 0.000 claims description 189
- 210000004027 cell Anatomy 0.000 claims description 134
- 108010008184 Aryldialkylphosphatase Proteins 0.000 claims description 124
- 102000006996 Aryldialkylphosphatase Human genes 0.000 claims description 124
- 230000014509 gene expression Effects 0.000 claims description 121
- 238000006460 hydrolysis reaction Methods 0.000 claims description 72
- 230000007062 hydrolysis Effects 0.000 claims description 70
- 108020004707 nucleic acids Proteins 0.000 claims description 69
- 102000039446 nucleic acids Human genes 0.000 claims description 69
- 150000007523 nucleic acids Chemical class 0.000 claims description 69
- 239000013612 plasmid Substances 0.000 claims description 69
- 102000004190 Enzymes Human genes 0.000 claims description 67
- 108090000790 Enzymes Proteins 0.000 claims description 67
- 230000003301 hydrolyzing effect Effects 0.000 claims description 47
- 108010021843 fluorescent protein 583 Proteins 0.000 claims description 33
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 32
- 238000009396 hybridization Methods 0.000 claims description 28
- 101100060067 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CIS1 gene Proteins 0.000 claims description 27
- 101100376208 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YGR035C gene Proteins 0.000 claims description 26
- 101100075909 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) IMA1 gene Proteins 0.000 claims description 19
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 17
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 17
- 239000005090 green fluorescent protein Substances 0.000 claims description 17
- 238000005415 bioluminescence Methods 0.000 claims description 14
- 230000029918 bioluminescence Effects 0.000 claims description 14
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- 108010063679 ice nucleation protein Proteins 0.000 claims description 13
- 241000243290 Aequorea Species 0.000 claims description 12
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 12
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 12
- 108090000363 Bacterial Luciferases Proteins 0.000 claims description 12
- 102000053187 Glucuronidase Human genes 0.000 claims description 12
- 108010060309 Glucuronidase Proteins 0.000 claims description 12
- 241000238631 Hexapoda Species 0.000 claims description 12
- 108010052090 Renilla Luciferases Proteins 0.000 claims description 12
- 101100507958 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HXT9 gene Proteins 0.000 claims description 12
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 12
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 12
- HUHWZXWWOFSFKF-UHFFFAOYSA-N uroporphyrinogen-III Chemical compound C1C(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(N2)=C(CC(O)=O)C(CCC(=O)O)=C2CC2=C(CCC(O)=O)C(CC(O)=O)=C1N2 HUHWZXWWOFSFKF-UHFFFAOYSA-N 0.000 claims description 12
- 102000055027 Protein Methyltransferases Human genes 0.000 claims description 11
- 108700040121 Protein Methyltransferases Proteins 0.000 claims description 11
- 210000000349 chromosome Anatomy 0.000 claims description 8
- 101100320753 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YLL056C gene Proteins 0.000 claims description 6
- 101100076600 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MET28 gene Proteins 0.000 claims description 5
- 101100161772 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POX1 gene Proteins 0.000 claims description 5
- 101100427436 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YHL012W gene Proteins 0.000 claims description 5
- 101100532024 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RTA1 gene Proteins 0.000 claims description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 3
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 claims description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 3
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims description 3
- 101100203980 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SPS100 gene Proteins 0.000 claims description 3
- 108010027293 diisopropyl-fluorophosphatase Proteins 0.000 claims description 3
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 claims description 3
- 230000003834 intracellular effect Effects 0.000 claims description 3
- -1 OpdA Proteins 0.000 claims description 2
- 230000001851 biosynthetic effect Effects 0.000 claims description 2
- 230000010354 integration Effects 0.000 claims 4
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 31
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 229960004623 paraoxon Drugs 0.000 description 244
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical compound CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 239
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 209
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 52
- 210000005253 yeast cell Anatomy 0.000 description 52
- 230000000694 effects Effects 0.000 description 50
- 229940088598 enzyme Drugs 0.000 description 44
- 241000588724 Escherichia coli Species 0.000 description 41
- 230000001965 increasing effect Effects 0.000 description 40
- 239000000047 product Substances 0.000 description 40
- 230000012010 growth Effects 0.000 description 36
- 101150021113 opd gene Proteins 0.000 description 36
- 239000012528 membrane Substances 0.000 description 33
- 239000000758 substrate Substances 0.000 description 31
- 230000006698 induction Effects 0.000 description 28
- 102000004169 proteins and genes Human genes 0.000 description 26
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 22
- 238000010208 microarray analysis Methods 0.000 description 21
- 108020004705 Codon Proteins 0.000 description 20
- 239000011942 biocatalyst Substances 0.000 description 20
- 239000013613 expression plasmid Substances 0.000 description 16
- 239000012634 fragment Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 15
- 231100000673 dose–response relationship Toxicity 0.000 description 15
- 230000004927 fusion Effects 0.000 description 15
- 229930182830 galactose Natural products 0.000 description 15
- 238000011144 upstream manufacturing Methods 0.000 description 15
- 239000012491 analyte Substances 0.000 description 14
- 238000003753 real-time PCR Methods 0.000 description 14
- 239000013598 vector Substances 0.000 description 14
- 238000010367 cloning Methods 0.000 description 13
- 239000006166 lysate Substances 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 12
- 210000005036 nerve Anatomy 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 11
- 239000000575 pesticide Substances 0.000 description 11
- 238000003757 reverse transcription PCR Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 230000035699 permeability Effects 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 210000002421 cell wall Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 101100451950 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HXT14 gene Proteins 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 239000008121 dextrose Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000589565 Flavobacterium Species 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 230000000593 degrading effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 102000034287 fluorescent proteins Human genes 0.000 description 7
- 108091006047 fluorescent proteins Proteins 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 101001077420 Homo sapiens Potassium voltage-gated channel subfamily H member 7 Proteins 0.000 description 6
- 102100025133 Potassium voltage-gated channel subfamily H member 7 Human genes 0.000 description 6
- 108700008625 Reporter Genes Proteins 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 6
- 229960005051 fluostigmine Drugs 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000006152 selective media Substances 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 241000793189 Saccharomyces cerevisiae BY4741 Species 0.000 description 5
- DYAHQFWOVKZOOW-UHFFFAOYSA-N Sarin Chemical compound CC(C)OP(C)(F)=O DYAHQFWOVKZOOW-UHFFFAOYSA-N 0.000 description 5
- 108091023040 Transcription factor Proteins 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 102000012440 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 4
- 101100389668 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) erg-4 gene Proteins 0.000 description 4
- 241000235070 Saccharomyces Species 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 238000005202 decontamination Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 4
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000010534 mechanism of action Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000003958 nerve gas Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001915 proofreading effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 108010039627 Aprotinin Proteins 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- GRPRVIYRYGLIJU-UHFFFAOYSA-N Demeton-S Chemical compound CCOP(=O)(OCC)SCCSCC GRPRVIYRYGLIJU-UHFFFAOYSA-N 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- GRXKLBBBQUKJJZ-UHFFFAOYSA-N Soman Chemical compound CC(C)(C)C(C)OP(C)(F)=O GRXKLBBBQUKJJZ-UHFFFAOYSA-N 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
- 241000607618 Vibrio harveyi Species 0.000 description 3
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 229960004373 acetylcholine Drugs 0.000 description 3
- 229940022698 acetylcholinesterase Drugs 0.000 description 3
- 230000002210 biocatalytic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003271 compound fluorescence assay Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 101150012212 prlC gene Proteins 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108090000204 Dipeptidase 1 Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 241001672999 Escura Species 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 239000005949 Malathion Substances 0.000 description 2
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
- 102000004203 Phosphoric Triester Hydrolases Human genes 0.000 description 2
- 108090000754 Phosphoric Triester Hydrolases Proteins 0.000 description 2
- 241000985694 Polypodiopsida Species 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 2
- 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 2
- PJVJTCIRVMBVIA-JTQLQIEISA-N [dimethylamino(ethoxy)phosphoryl]formonitrile Chemical compound CCO[P@@](=O)(C#N)N(C)C PJVJTCIRVMBVIA-JTQLQIEISA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000007073 chemical hydrolysis Effects 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 230000008686 ergosterol biosynthesis Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 229960000453 malathion Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 238000012913 prioritisation Methods 0.000 description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 2
- 238000009790 rate-determining step (RDS) Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000011870 unpaired t-test Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MNULEGDCPYONBU-WMBHJXFZSA-N (1r,4s,5e,5'r,6'r,7e,10s,11r,12s,14r,15s,16s,18r,19s,20r,21e,25s,26r,27s,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trio Polymers O([C@@H]1CC[C@@H](/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]([C@H]2C)[C@H]1C)CC)[C@]12CC[C@@H](C)[C@@H](C[C@H](C)O)O1 MNULEGDCPYONBU-WMBHJXFZSA-N 0.000 description 1
- MNULEGDCPYONBU-DJRUDOHVSA-N (1s,4r,5z,5'r,6'r,7e,10s,11r,12s,14r,15s,18r,19r,20s,21e,26r,27s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers O([C@H]1CC[C@H](\C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)C(C)C(=O)[C@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)OC([C@H]2C)C1C)CC)[C@]12CC[C@@H](C)[C@@H](CC(C)O)O1 MNULEGDCPYONBU-DJRUDOHVSA-N 0.000 description 1
- FDYMERLIFOUIRZ-UHFFFAOYSA-N (3-chloro-4-methyl-2-oxochromen-7-yl) diethyl phosphate Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=O)(OCC)OCC)=CC=C21 FDYMERLIFOUIRZ-UHFFFAOYSA-N 0.000 description 1
- MNULEGDCPYONBU-YNZHUHFTSA-N (4Z,18Z,20Z)-22-ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione Polymers CC1C(C2C)OC(=O)\C=C/C(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)C\C=C/C=C\C(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-YNZHUHFTSA-N 0.000 description 1
- MNULEGDCPYONBU-VVXVDZGXSA-N (5e,5'r,7e,10s,11r,12s,14s,15r,16r,18r,19s,20r,21e,26r,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers C([C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)OC([C@H]1C)[C@H]2C)\C=C\C=C\C(CC)CCC2OC21CC[C@@H](C)C(C[C@H](C)O)O2 MNULEGDCPYONBU-VVXVDZGXSA-N 0.000 description 1
- IFZVKYXDCOHPOT-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethanethiol Chemical compound CC(C)N(C(C)C)CCS IFZVKYXDCOHPOT-UHFFFAOYSA-N 0.000 description 1
- UTPHRZRWMXLNIK-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethanethiol;hydron;chloride Chemical compound Cl.CC(C)N(C(C)C)CCS UTPHRZRWMXLNIK-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- MNULEGDCPYONBU-UHFFFAOYSA-N 4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers CC1C(C2C)OC(=O)C=CC(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)CC=CC=CC(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- YHQDZJICGQWFHK-UHFFFAOYSA-N 4-nitroquinoline N-oxide Chemical compound C1=CC=C2C([N+](=O)[O-])=CC=[N+]([O-])C2=C1 YHQDZJICGQWFHK-UHFFFAOYSA-N 0.000 description 1
- WLHQSAYHIOPMMJ-UOQFGJKXSA-N 7-aminocholesterol Chemical compound NC1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 WLHQSAYHIOPMMJ-UOQFGJKXSA-N 0.000 description 1
- ANJAOCICJSRZSR-WAYWQWQTSA-N 9Z-Tetradecenal Chemical compound CCCC\C=C/CCCCCCCC=O ANJAOCICJSRZSR-WAYWQWQTSA-N 0.000 description 1
- 102100033094 ATP-binding cassette sub-family G member 4 Human genes 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
- 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
- 101100068321 Aequorea victoria GFP gene Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000590031 Alteromonas Species 0.000 description 1
- 101100281515 Arabidopsis thaliana FOX1 gene Proteins 0.000 description 1
- 241000237519 Bivalvia Species 0.000 description 1
- 241000589539 Brevundimonas diminuta Species 0.000 description 1
- 101150001086 COB gene Proteins 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 206010008428 Chemical poisoning Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000005469 Chitin Synthase Human genes 0.000 description 1
- 108700040089 Chitin synthases Proteins 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101100468517 Danio rerio rbfox1l gene Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108091027757 Deoxyribozyme Proteins 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 101150040602 ERG4 gene Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- YTNIXZGTHTVJBW-SCRDCRAPSA-L FMNH2(2-) Chemical compound [O-]P(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O YTNIXZGTHTVJBW-SCRDCRAPSA-L 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000589564 Flavobacterium sp. Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 101150087110 HCRT gene Proteins 0.000 description 1
- 101000800393 Homo sapiens ATP-binding cassette sub-family G member 4 Proteins 0.000 description 1
- 101000587820 Homo sapiens Selenide, water dikinase 1 Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229910009891 LiAc Inorganic materials 0.000 description 1
- 101001044957 Loligo vulgaris Diisopropyl-fluorophosphatase Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- WXJXBKBJAKPJRN-UHFFFAOYSA-N Methanephosphonothioic acid Chemical compound CP(O)(O)=S WXJXBKBJAKPJRN-UHFFFAOYSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 108010006769 Monosaccharide Transport Proteins Proteins 0.000 description 1
- 102000005455 Monosaccharide Transport Proteins Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001148064 Photorhabdus luminescens Species 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 101100508066 Pseudomonas syringae pv. syringae inaZ gene Proteins 0.000 description 1
- 101150073947 RBFOX1 gene Proteins 0.000 description 1
- 102100038188 RNA binding protein fox-1 homolog 1 Human genes 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 101150030513 SNQ2 gene Proteins 0.000 description 1
- 101100310480 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SMI1 gene Proteins 0.000 description 1
- 101100320782 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YLR287C gene Proteins 0.000 description 1
- 101100267625 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YOR186W gene Proteins 0.000 description 1
- 101100288418 Staphylococcus xylosus lacP gene Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000012163 TRI reagent Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 108091005971 Wild-type GFP Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- ANJAOCICJSRZSR-UHFFFAOYSA-N Z9-14:Ald Natural products CCCCC=CCCCCCCCC=O ANJAOCICJSRZSR-UHFFFAOYSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 101150098767 btuR gene Proteins 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000003654 cell permeability assay Methods 0.000 description 1
- 230000004656 cell transport Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002575 chemical warfare agent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 101150087945 cobA gene Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FAXIJTUDSBIMHY-UHFFFAOYSA-N diethoxy-(2-ethylsulfanylethoxy)-sulfanylidene-$l^{5}-phosphane;1-diethoxyphosphorylsulfanyl-2-ethylsulfanylethane Chemical compound CCOP(=O)(OCC)SCCSCC.CCOP(=S)(OCC)OCCSCC FAXIJTUDSBIMHY-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 101150050623 erg-6 gene Proteins 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- XDNBJTQLKCIJBV-UHFFFAOYSA-N fensulfothion Chemical compound CCOP(=S)(OCC)OC1=CC=C(S(C)=O)C=C1 XDNBJTQLKCIJBV-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000001871 ion mobility spectroscopy Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 238000013173 literature analysis Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 101150079876 mcrB gene Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229930191479 oligomycin Natural products 0.000 description 1
- MNULEGDCPYONBU-AWJDAWNUSA-N oligomycin A Polymers O([C@H]1CC[C@H](/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]([C@@H]2C)[C@@H]1C)CC)[C@@]12CC[C@H](C)[C@H](C[C@@H](C)O)O1 MNULEGDCPYONBU-AWJDAWNUSA-N 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000858 peroxisomal effect Effects 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000012755 real-time RT-PCR analysis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000009295 sperm incapacitation Effects 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000010897 surface acoustic wave method Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 208000018878 young-onset Parkinson disease Diseases 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
- 108010082737 zymolyase Proteins 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Definitions
- a yeast biosensor may include a defect (e.g., mutation) in (a) cell wall synthesis, maintenance, or degradation, (b) cell membrane synthesis, maintenance, or degradation, (c) cell repair, and/or (d) cell transport (e.g., drug export pump or import pump).
- a yeast biosensor may include one or more proteins and/or nucleic acid(s) encoding one or more proteins capable of actively importing a chemical agent into the sensor.
- This method may further include confirming differential expression by quantitative reverse transcription PCR.
- the present disclosure also relates to a method of identifying a yeast gene that is upregulated by or during organosphosphate hydrolysis.
- this method may include (a) contacting a recombinant OPH+ yeast with an organophosphate under conditions that permit organophosphate hydrolysis, (b) collecting RNA from the recombinant OPH+ yeast, (c) contacting the subtracted RNA with a yeast mircoarray having feature loci that correspond to yeast genes under conditions that permit hybridization of complimentary sequences, (d) comparing a metric of the hybridization at each feature locus with the same metric of hybridization at a corresponding feature locus for RNA from yeast lacking OPH contacted with the organophosphate, (e) identifying a feature locus where the hybridization metric is higher for the recombinant OPH+ yeast contacted with the organophosphate than the yeast lacking OPH contacted with the organophosphate, and (f) correlating
- a yeast biosensor that is sensitive to both an organophosphate and an organophosphate hydrolytic product may be prepared by (a) identifying a yeast gene that is upregulated by an organophosphate, (b) identifying at least one expression control sequence of the identified organophosphate-sensitive gene, (c) operably linking a nucleic acid comprising the organophosphate expression control sequence to a nucleic acid encoding a reporter, (d) contacting the operably linked organophosphate nucleic acids with a cell under conditions that permit uptake of the nucleic acids, (e) identifying a yeast gene that is upregulated by an organophosphate hydrolytic product and/or by a process of organophosphate hydrolysis, (f) identifying at least one expression control sequence of the identified organophosphate hydrolysis- sensitive gene, (g) operably linking a nucleic acid comprising the organophosphate hydrolytic product expression control sequence to a nucleic acid encoding a reporter, and (h) contacting the operably linked organophosphate hydro
- FIGURE 9B is a chart illustrating the effect of 0.5 mM paraoxon on the growth (monitored at A 6 oo) of S. cerevisiae wild-type (BY4741) and the membrane mutant strain erg4;
- the comparison between wild-type cells incubated with VX, and recombinant cells expressing OPH incubated with VX, may facilitate identification of one or more yeast genes induced by the hydrolysis of VX. Hydrolysis of VX using a yeast strain expressing OPH may result in a transcriptional profile that is distinct from cells lacking the ability to hydrolyze VX. Real-time RT-PCR may then be used on prioritized targets using different concentrations of VX to identify yeast genes that are induced at low concentrations and in a dose-dependent manner. Promoter regions of prioritized genes may be mapped using the
- the GAPDH promoter or a similarly highly expressed constitutive promoter may be used to drive foreign gene expression in yeast.
- the GAPDH promoter may be operably linked (e.g. , positioned adjacent to) the opd gene such that the opd gene is constitutively expressed.
- clonal cells each harboring a specific biodegrading enzyme and specific reporter detection system for a specific chemical, may be mixed into a heterogeneous population that as a group, can detect and biodegrade different chemical agents.
- the Flavobacterium opd gene is identical to the Pseudomonas putida opd gene (Mulbry WW & Karns JS., (1989) J Bacteriol 171, 6740-6).
- a lkb opd fragment was PCR-amplified using a proofreading thermostable polymerase (Fig. 1).
- the 5' primer was designed to incorporate a yeast ribosome binding site to ensure optimal translation initiation (Looman AC & Kuivenhoven JA., (1983) Nuc Acids Res 21, 4268-71).
- the 5' and 3' primers were also designed to incorporate the restriction endonuclease sites BamHl and Hind ⁇ ll, respectively.
- RNA was prepared using Tri reagent (Ambion) according to the manufacturers' instructions and treated with DNasel. Equal amounts of RNA (approximately 1 ⁇ g) were reverse transcribed into cDNA using the retroscript kit (Ambion). PCR was performed initially with primers designed against the S. cerevisiae housekeeping gene actin (ACTl, 547 bp product) to ensure equal amounts of cDNA were used for each sample; if required, the amount of cDNA template was then adjusted accordingly before opd analysis. PCR products were resolved and analyzed using agarose gel electrophoresis. PCR analysis was also performed with samples that lacked reverse transcriptase (RNA samples); no RT-PCR products were detected from these samples as expected.
- RNA samples reverse transcriptase
- Opd expression is not toxic to S. cerevisiae; however, there was a slight inhibition in the growth rate of yeast cells harboring the opd plasmid under inducing conditions.
- Control enzyme lysates prepared from yeast cells harboring the empty plasmid, were not able to hydrolyze paraoxon.
- yeast cells harboring the opd expression plasmid produced functional OPH protein that hydrolyzed paraoxon (Table 1).
- Most (75%) of the enzyme activity in S. cerevisiae was membrane associated (triton extractable) with the remainder in the cytosolic fraction. This distribution is comparable to the wild-type Flavobacterium species (Mulbry WW & Karns JS., (1989) J Bacteriol 171, 6740-6).
- Intact recombinant yeast cells were capable of hydrolyzing paraoxon and functioning as a yeast biocatalyst. Intact yeast cells displayed lower paraoxon hydrolysis compared to enzyme lysates presumably because a rate limiting step is the rate of paraoxon diffusion into the cell.
- YeGFP is codon optimized for expression in the yeast Candida albicans, and is also highly fluorescent in S. cerevisiae (Cormack BP et al., (1997) Microbiology 143, 303-11).
- a strain of C. albicans containing YeGFP was used.
- the 700 bp YeGFP gene was PCR-amplified using a proofreading polymerase and C. albicans YeGFP genomic DNA as template.
- the PCR primers were designed to contain BamRl and Spel endonuclease sites for cloning into the respective sites of pESC-HIS.
- YGR035C and YLR346C promoters 2 putative promoter fragments for each gene containing approximately -1000 and - 500 bp upstream sequence (relative to ATG) were cloned in front of YeGFP.
- the putative promoter regions were PCR-cloned using £. cerevisiae W3031A genomic DNA as template and a proofreading thermostable DNA polymerase.
- the 5' and 3' primers contained SaR and Barri ⁇ l sites, respectively, for directional cloning into the same sites of p YeGFP-HIS to generate promoter-reporter gene fusions.
- Yeast cells harboring paraoxon-inducible promoter- YeGFP fusions displayed up to 5-fold increases in fluorescence levels compared to control cells when incubated in the presence of paraoxon. Increased YeGFP levels were detected after 15 min exposure to paraoxon.
- the YeGFP biosensor was sensitive to as low as 0.1 mM paraoxon and exhibited dose-dependent characteristics by increasing YeGFP fluorescence as the paraoxon concentration increased. The results demonstrate the ability of yeast cells to function as a biosensor and detect the presence of paraoxon.
- the yeast codon optimized DsRed, YDsRed was also designed to contain a preferred yeast ribosome binding site and BamHI and Notl restriction endonuclease sites for cloning into the corresponding sites of pESC-LEU (Stratagene).
- the resulting pYDsRed-LEU promoterless vector contained an adequate MCS for cloning the POXl and YGR287C promoters.
- Cells were grown in SDgal/suc lacking leucine in the presence or absence of 3 niM paraoxon for 4.5 h at 37° C. Cells were harvested by centrifugation, washed in PBS, resuspended in 10 mM Tris-HCl pH 8.5, and duplicate samples were measured for YDsRed fluorescence (excitation and emission at 554 nm and 590 nm, respectively). All results were normalized to the number of cells present (OD 6 oo), to the 'promoterless' control vector (YDsRed-LEU) and are presented as fold-induction compared to cells lacking paraoxon.
- Promoter Fold-induction 8 Promoter Fold-induction 1 * pYGR287C-Fl 1.41 pYGR287C-Fl 2.1 pYGR287C-F2 1.13 pYGR287C-F2 2.4 pPOXl-Fl 0.84 pPOXl-Fl 3.0
- POXl promoter (525 cerevisiae bp upstream of ATG) driving YDsRed pYGR287C-F 1 -YDsRed-LEU E. coli/S. YGR287C promoter cerevisiae (993 bp upstream of
- Bold indicates the BamHl or SaR restriction site for cloning into the corresponding sites of YeGFP-His or YDsRed-LEU.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74088705P | 2005-11-30 | 2005-11-30 | |
| PCT/US2006/045761 WO2007145661A2 (fr) | 2005-11-30 | 2006-11-29 | Biocapteurs fluorescents différentiels à levure pour la détection et la biodégradation d'agents chimiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1963538A2 true EP1963538A2 (fr) | 2008-09-03 |
Family
ID=38832244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06851299A Withdrawn EP1963538A2 (fr) | 2005-11-30 | 2006-11-29 | Biocapteurs fluorescents différentiels à levure pour la détection et la biodégradation d'agents chimiques |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1963538A2 (fr) |
| JP (1) | JP2009518006A (fr) |
| WO (1) | WO2007145661A2 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100221817A1 (en) * | 2007-04-25 | 2010-09-02 | Technische Universitaet Dresden | Whole-Cell Sensor |
| EP2441834A1 (fr) | 2007-10-01 | 2012-04-18 | Guild Associates, Inc. | Biocapteurs de levure différentiellement fluorescente pour la détection et la biodégradation d'agents chimiques |
| TR201901939T4 (tr) * | 2014-03-12 | 2019-03-21 | Nat Center Neurology & Psychiatry | Antisens nükleik asit. |
| US10988759B2 (en) | 2016-01-15 | 2021-04-27 | University Of Washington | High throughput protein-protein interaction screening in yeast liquid culture |
| WO2021231013A1 (fr) | 2020-05-11 | 2021-11-18 | A-Alpha Bio, Inc. | Procédés de criblage à haut rendement pour identifier des cibles de petites molécules |
| EP4158015A1 (fr) | 2020-06-01 | 2023-04-05 | A-Alpha Bio, Inc. | Procédés de caractérisation et d'ingénierie d'interactions protéine-protéine |
| CN115753714B (zh) * | 2022-11-21 | 2024-06-04 | 清华大学 | 一种生物传感器、核酸分子、表达载体及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117643A (en) | 1997-11-25 | 2000-09-12 | Ut Battelle, Llc | Bioluminescent bioreporter integrated circuit |
| ATE340266T1 (de) | 1999-04-26 | 2006-10-15 | Us Army Med Res Mat Command | Immobilisierte enzyme als biosensoren fur chemische toxine |
| US20080044844A1 (en) | 2004-01-27 | 2008-02-21 | Shimshon Belkin | Populations Of Cells And Devices And Systems Including Same |
-
2006
- 2006-11-29 EP EP06851299A patent/EP1963538A2/fr not_active Withdrawn
- 2006-11-29 JP JP2008543437A patent/JP2009518006A/ja not_active Withdrawn
- 2006-11-29 WO PCT/US2006/045761 patent/WO2007145661A2/fr not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| GOFFEAU A ET AL: "LIFE WITH 6000 GENES", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US LNKD- DOI:10.1126/SCIENCE.274.5287.546, vol. 274, 25 October 1996 (1996-10-25), pages 546,563 - 567, XP002070912, ISSN: 0036-8075 * |
| See also references of WO2007145661A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009518006A (ja) | 2009-05-07 |
| WO2007145661A3 (fr) | 2008-04-10 |
| WO2007145661A2 (fr) | 2007-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0673439B2 (fr) | Procédé pour la détection d'agressions de l'environnement | |
| US8927244B2 (en) | Organophosphorus hydrolase | |
| Houser et al. | An improved short‐lived fluorescent protein transcriptional reporter for Saccharomyces cerevisiae | |
| CA2200702C (fr) | Reactif bacterien bioluminescent lyophilise servant a la detection d'agents toxiques | |
| Holesova et al. | Gentisate and 3-oxoadipate pathways in the yeast Candida parapsilosis: identification and functional analysis of the genes coding for 3-hydroxybenzoate 6-hydroxylase and 4-hydroxybenzoate 1-hydroxylase | |
| KR20120099202A (ko) | 재설계 유전자회로를 이용한 목적 효소 활성의 신규 탐색 및 정량 방법 | |
| Kumar et al. | Utilization of glutathione as an exogenous sulfur source is independent of γ-glutamyl transpeptidase in the yeast Saccharomyces cerevisiae: evidence for an alternative gluathione degradation pathway | |
| Cao et al. | Catabolic pathways and cellular responses of Pseudomonas putida P8 during growth on benzoate with a proteomics approach | |
| Nasution et al. | Loss of D fg5 glycosylphosphatidylinositol‐anchored membrane protein confers enhanced heat tolerance in S accharomyces cerevisiae | |
| EP1963538A2 (fr) | Biocapteurs fluorescents différentiels à levure pour la détection et la biodégradation d'agents chimiques | |
| Schofield et al. | Development of a yeast biosensor–biocatalyst for the detection and biodegradation of the organophosphate paraoxon | |
| He et al. | The fungal mitochondrial membrane protein, BbOhmm, antagonistically controls hypoxia tolerance | |
| Makkar et al. | Enzyme-mediated bioremediation of organophosphates using stable yeast biocatalysts | |
| CN1726290A (zh) | 产生用于筛选活性物质的经遗传修饰生物的方法 | |
| Escusa et al. | Proteasome‐and SCF‐dependent degradation of yeast adenine deaminase upon transition from proliferation to quiescence requires a new F‐box protein named Saf1p | |
| Iradi-Serrano et al. | The early asexual development regulator fluG codes for a putative bifunctional enzyme | |
| EP0943000A1 (fr) | Procede tres sensible de detection sur de faibles volumes des atteintes a l'environnement | |
| CN101605888A (zh) | 使用转化的贝利不动杆菌adp1作为生物传感器检测甲苯和二甲苯的方法 | |
| Collins et al. | Variation in ubiquitin system genes creates substrate-specific effects on proteasomal protein degradation | |
| Mokry et al. | Heterologous expression studies of Saccharomyces cerevisiae reveal two distinct trypanosomatid CaaX protease activities and identify their potential targets | |
| Toussaint et al. | Whole-cell biosensor of cellobiose and application to wood decay detection | |
| Cordero et al. | Carbon monoxide dehydrogenases enhance bacterial survival by oxidising atmospheric CO | |
| JP2003093047A (ja) | 環境因子の測定に用いる微生物 | |
| CN113528412B (zh) | 一种基于大肠杆菌细胞表面展示技术的爆炸物可视化生物传感器及其制备方法和应用 | |
| EP1693465B1 (fr) | Methode d'analyse d'agent chimique a l'aide d'une souche genetique disloquee |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20080627 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| 17Q | First examination report despatched |
Effective date: 20090112 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20110621 |